COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,554 Articles (22,400 medRxiv, 8,154 bioRxiv)

Most recent first Previous |  Page 2031: Articles 20301-20310  | Next

Precision shielding for COVID-19: metrics of assessment and feasibility of deployment
Ioannidis, J.
10.1101/2020.11.01.20224147 — Posted: 2020-11-04
Experience from a COVID-19 screening centre of a tertiary care institution: A retrospective hospital-based study
Pradhan, S. K., Sahu, D. P., Sahoo, D. P., Patro, B. K., Singh, A. K., Mohanty, S.
10.1101/2020.11.01.20224105 — Posted: 2020-11-04
SARS-CoV-2 Testing Disparities in Massachusetts
Dryden-Peterson, S., Velasquez, G. E., Stopka, T. J., Davey, S., Lockman, S., Ojikutu, B. O.
10.1101/2020.11.02.20224469 — Posted: 2020-11-04
The CCR5-delta32 variant might explain part of the association between COVID-19 and the chemokine-receptor gene cluster
GOMEZ, J., CUESTA-LLAVONA, E., ALBAICETA, G. M., GARCIA-CLEMENTE, M., LOPEZ-LARREA, C., AMADO, L., LOPEZ-ALONSO, I., HERMIDA, T., ENRIQUEZ, A., GIL, H., ALONSO, B., IGLESIAS, S., SUAREZ-ALVAREZ, B., ALVAREZ, V., COTO, E.
10.1101/2020.11.02.20224659 — Posted: 2020-11-04
The signature features of COVID-19 pandemic in a hybrid mathematical model - implications for optimal work-school lockdown policy
Lazebnik, T., Bunimovich-Mendrazitsky, S.
10.1101/2020.11.02.20224584 — Posted: 2020-11-04
Rapid homogeneous assay for detecting antibodies against SARS-CoV-2
Rusanen, J., Kareinen, L., Levanov, L., Mero, S., Pakkanen, S. H., Kantele, A., Amanat, F., Krammer, F., Hedman, K., Vapalahti, O., Hepojoki, J.
10.1101/2020.11.01.20224113 — Posted: 2020-11-04
A household case evidences shorter shedding of SARS-CoV-2 in naturally infected cats compared to their human owners.
Neira Ramirez, V., Brito, B., Aguero, B., Berrios, F., Valdes, V., Gutierrez, A., Ariyama, N., Espinoza, P., Retamal, P., Holmes, E. C., Gonzalez-reiche, A., Khan, Z., Van de Guchte, A., Dutta, J., Miorin, L., Kehrer, T., Galarce, N., Almonacid, L., Levican, J., van Bakel, H., Garcia-Sastre, A., Medina, R. A.
10.1101/2020.10.31.20220608 — Posted: 2020-11-04
Personalized Prescription of ACEI/ARBs for Hypertensive COVID-19 Patients
Bertsimas, D., Borenstein, A., Mingardi, L., Nohadani, O., Orfanoudaki, A., Stellato, B., Wiberg, H., Sarin, P., Varelmann, D., Estrada, V., Macaya, C., Nunez Gil, I.
10.1101/2020.10.30.20223594 — Posted: 2020-11-04
SARS-CoV-2 Innate Effector Associations and Viral Load in Early Nasopharyngeal Infection
Liou, T. G., Adler, F. R., Cahill, B. C., Cox, D. R., Cox, J. E., Grant, G. J., Hanson, K. E., Hartsell, S. C., Hatton, N. D., Helms, M. N., Jensen, J. L., Kartsonaki, C., Li, Y., Leung, D. T., Marvin, J. E., Middleton, E. A., Osburn-Staker, S. M., Packer, K. A., Shakir, S. M., Sturrock, A. B., Tardiff, K. D., Warren, K. J., Waddoups, L. J., Weaver, L. J., Zimmerman, E., Paine, R.
10.1101/2020.10.30.20223545 — Posted: 2020-11-04
Early COVID-19 Therapy with Azithromycin Plus Nitazoxanide, Ivermectin or Hydroxychloroquine in Outpatient Settings Significantly Reduced Symptoms Compared to Known Outcomes in Untreated Patients.
Cadegiani, F. A., Goren, A., Wambier, C. G., McCoy, J.
10.1101/2020.10.31.20223883 — Posted: 2020-11-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).